Asia Pacific Local Anaesthetic Drug Market Report

Asia Pacific Local Anaesthetic Drug Market Report, by Drug (Bupivacaine, Lidocaine, Benzocaine, Ropivacaine, Prilocaine, Chloroprocaine), Route of Administration (Intravenous Local Anaesthesia, Ophthalmic Anaesthesia), Distribution Channel (Online Retail Pharmacies, Retail Pharmacies, Hospital Pharmacies) and Country - Asia Pacific Market Share, Trend, Analysis & Forecast , 2019 - 2028

Report Code : 10731 | Publish Date : Upcoming | Industry : Healthcare | Geography : APAC


Anaesthesia is a medical procedure which reduces the pain during surgery and other painful medical processes. It initiates the loss of awareness and sensation to the patient, which helps surgeon for carrying entire surgery. The anaesthesia is a drug which prevents pain during a surgical procedure. The anaesthesia type used for surgeries is govern by various factors like length and type of the surgery, patient health and preference of the surgeon doctor and patients. There are three types of anaesthesia drugs are local anaesthesia, general anaesthesia and regional anaesthesia. Local anaesthesia is injected in the tissues to numb the specific part of the body for minor surgical operations. In general anaesthesia, the patient is totally unconscious and haven’t feel any sense in the body and regional anaesthesia is comprised of injection near the cluster nerve for numbness of body parts. 

Market Dynamics - Asia Pacific Local Anaesthetic Drug Market 

The Asia Pacific local anaesthetic drug market is witnessing lucrative growth during the forecast period of 2021-2027. The local anaesthetic medicines cause the reversible loss of sensation or pain in specific body part which is acquired by topical application or injection of local anaesthetics. The major factors like growing number of surgeries is propelling growth of Asia Pacific local anaesthetic drug market. The emergence of modern and effective drugs is also refuelling growth of Asia Pacific local anaesthetic drug market. The increasing healthcare expenditure in developing countries is also boosting the growth of Asia Pacific local anaesthetic drug market. However, regulatory issues by government is hampering the growth of Asia Pacific local anaesthetic drug market. 

COVID-19 Impact on Asia Pacific Local Anaesthetic Drug Market 

The exclusive COVID-19 impact analysis report by Axiom MRC provides a 3600 analysis of micro and macro-economic factors on the local anaesthetic drug market. In addition, complete analysis of changes on local anaesthetic drug expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on Asia Pacific economies, international trade, business investments, GDP and marketing strategies of key players present in the market. There is slight slow growth of local anaesthetic drug market is experienced during the COVID-19 situation as there is several restraining factors like mismatch between demand and supply due to complete shutdown in many countries which hampered the transportation of general anaesthetic drugs. The several surgical procedures are post ponded during the time of COVID-19 pandemic. However, activities are resuming and all the pending surgeries are being held nowadays. The market acquired its original state and witnessing rapid growth during the forecast period 2021-2027. 


Asia Pacific Local Anaesthetic Drug Market - Segmental Overview 

The Asia Pacific local anaesthetic drug market is bifurcated by drug molecules, route of administration, distribution channel and country. 

Asia Pacific Local Anaesthetic Drug Market by Drug Molecule 

The drug molecules like bupivacaine, lidocaine, benzocaine, ropivacaine, prilocaine, Chloroprocaine and other local anaesthetic drugs are comprised in the Asia Pacific local anaesthetic drug market. In which bupivacaine is also contributing in the growth of Asia Pacific local anaesthetic drug market. Bupivacaine is prescription-based medication which used for numbing of targeted body part or injected into the spinal canal’s epidural space. It blocks the nerve impulses which send signal to brain. It is available in various brand names like Marcaine and Sensorcaine. The half-life of bupivacaine is 3.1 hrs in adults and 8.1 hrs in neonates and has onset of action in 15 minutes and last up to two to eight hours.

Asia Pacific Local Anaesthetic Drug Market by Route of Administration

The route of administrations like intravenous local anaesthesia, topical local anaesthesia and ophthalmic local anaesthesia are comprised in the Asia Pacific local anaesthetic drug market. In which intravenous route is expected to dominate the market in 2020. The intravenous administration implies rapid onset of sensory and motor block, reduced intraoperative and tourniquet pain, prolonged post-surgical analgesia and minimum side effects are owing to propel growth of segment in Asia Pacific local anaesthetic drug market. Additionally, intravenous local anaesthetic have better intestinal motility and reduced opioid consumptions. 

Asia Pacific Local Anaesthetic Drug Market by Distribution Channel

The distribution channels like online pharmacies, retail pharmacies and hospital pharmacies are comprised in Asia Pacific local anaesthetic drug market. In which hospital pharmacies is expected to dominate the market in 2020. The high patient outflow of outpatients is propelling the growth of Asia Pacific local anaesthetic drug market. The adoption of technically advanced healthcare equipment is also refuelling the growth of Asia Pacific local anaesthetic drug market. The growing population is also elevating growth of Asia Pacific local anaesthetic drug market. 

Asia Pacific Local Anaesthetic Drug Market by Country 

The Asia Pacific local anaesthetic drug market is studied for countries like India, Japan, China, Australia and South Korea. In which China and India are anticipated to dominate the market in 2020. The rising healthcare expenditure is propelling the growth of Asia Pacific local anaesthetic drug market. The rising surgical procedures in region is also refuelling the growth of Asia Pacific local anaesthetic drug market. Adoption of technologically advanced healthcare equipment is also elevating growth of Asia Pacific local anaesthetic drug market. The rising collaboration and new product launch is also contributing in the growth of Asia Pacific local anaesthetic drug market. 

Key Players in Local Anaesthetic Drug Market 

The key players operating in the local anaesthetic drug market are Advanced Pharma Inc., Akorn Inc., Aspen Pharmacare, Baxter International Inc., Fresenius Kabi, Glenmark Pharmaceuticals Inc., Mylan, Novartis Ag, Pacira Pharmaceutical, Pfizer Inc., Sagent Pharmaceutical and Teva Pharmaceutical Industries Ltd. among the others.

Key Developments in Local Anaesthetic Drug Market 

November 2018: The Septodont announced lauching of Dentapen electronic syringe for application in dental anaesthesia.

April 2018: The B. Braun Medical Inc. launched its first FDA- approved local anaesthetic for use in spinal anaesthesia named Clorotekal® which comprised of Chloroprocaine hydrochloride.

•   Astrazeneca offers various anaesthetic products in its product portfolio like Carbocaine (mepivacaine). Citanest (prilocaine), Dipitan (propofol), EMLA (lidocaine + prilocaine), Marcaine (bupivacaine), Naproin (ropivacaine) along with Xylocaine (lidocaine/ lignocaine).

•   Glenmark Pharmaceutical marketed lidocaine ointment name Fougera for topical anaesthetic purpose comprised of lidocaine ointment USP, 5%.

The study comprised of local anaesthetic drug market. In which different segment of market are analysed. The market segments like drug molecules, route of administrations and distribution channels are analysed in the study. The study also imparts the dominating segments of the market. The drug molecules segment is dominated by lidocaine. Likewise, route of administration segment is dominated by intravenous route and distribution channel is dominated by hospital pharmacies. The study also imparts the geographical section of the market and it analysed that China and India is dominating the market in 2020. The study also imparts impact of COVID-19 on local anaesthetic drug market and it concludes that there is slight slow growth of local anaesthetic drug market is experienced during the COVID-19 situation as there is several restraining factors like mismatch between demand and supply due to complete shutdown in many countries which hampered the transportation of general anaesthetic drugs. The several surgical procedures are post ponded during the time of COVID-19 pandemic. However, activities are resuming and all the pending surgeries are being held nowadays. The market acquired its original state and witnessing rapid growth during the forecast period 2021-2027. The study also analysed various key players operating in the market. 

Why to buy this report 

  • The report offers changing market dynamics in the local anaesthetic drug markets industry, presenting historical, current and projected market size in terms of value (USD Million)
  • The research study provides an in-depth analysis of the industry value chain focusing on the peer and parent markets of the local anaesthetic drug market
  • It presents a comprehensive assessment of countries exhibiting promising growth, potential and niche segments and a neutral perspective of the local anaesthetic drug market
  • The report also offers strategic recommendations in key business segments based on the market estimations and competitive landscape, mapping the key common trends of local anaesthetic drug market